ADAKU OGOKE: Open Payments
NPI 1184121170 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 29 payments from 8 companies in 2025. Trend: 2023 $1,417 · 2024 $1,387 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 8 | $211 |
| Gilead Sciences, Inc. | 3 | $140 |
| Braeburn Inc. | 6 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| ABBVIE INC. | 3 | $73 |
| Alkermes, Inc. | 3 | $69 |
| Orexo US, Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
Products named: SUBLOCADE, BRIXADI, Epclusa, CAPLYTA, VRAYLAR, VIVITROL, Zubsolv, INGREZZA.
Industry payments across MD — which companies pay providers there.
